Drugs / AGANEPAG ISOPROPYL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01110499 | Jun 2010 → May 2011 | ocular hypertension, open-angle glaucoma | Allergan | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AGANEPAG ISOPROPYL | ChEMBL registry synonym — accepted as the source's own label CHEMBL2105714 ↗ |
| Known as | AGN-210961 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01110499 ↗ |
| Modality | Small molecule | — CHEMBL2105714 ↗ |
| Route | Other | “AGN-210961 ophthalmic solution” NCT01110499 ↗ |